(Date:9/5/2008)...5 /PRNewswire-USNewswire/ -- As the general electi...Federation of Independent,Business ( http://www.nf...ates for a greater focus on the healthcare concern...epublican conventions are over, NFIB,is asking bot...tacles faced,by small businesses as they further d...
(Date:9/5/2008)...r risk prediction models are enhanced by taking in...NA repair capacity, according to research teams le... D. Anderson Cancer Center in two complementary pa...revention Research . , In the first study to foc...results based on increased exposure to certain ris...
(Date:9/4/2008)...a case-control study, the presence of measles viru...nd GI disturbances than in children with only GI d...nset were unrelated to MMR vaccine timing. Study ...y of Science on September 4 ( http://dx.plos.org/...mplementation of measles vaccines in 1963, three t...
(Date:9/4/2008)... Medelis, an oncology contract research organiz...nical Trials: A Nuanced Approach to Get Into the C...arry, a preclinical research scientist with 35 yea...al studies are commonly viewed as straightforward ...operate without true integration with preclinical,...
Breaking Medicine News(10 mins):Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 2Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 3Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 2Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3...vered a potential new target, Akt2/PKB, a fat meta...er, PGC-1a for the treatment of type 2 diabetes. ...led by Morris J. Birnbaum at the University of Pen...icine. When a person eats, insulin is secreted by...
... to reel under a scorching June sun with most area...s Friday and Sri Ganganagar in Rajasthan at a sear... clouds were nowhere in sight. Following close b...as Amritsar in Punjab with a maximum of 46 degrees...
... conduct psychological tests on its recruits in a ...atricides that have occurred in the past few years...new tests (being introduced from October), we woul...f a recruit, his ability to grasp a given situatio...
...pitals Friday said that its recently launched Ches... and save lives of cardiac patients. The hospita...t week to address the need of preventing the loss ...e lives. Anil Maini, president, corporate develop...
Other Medicine News:Health News:Army to Conduct Psychological Tests During Recruits to Curb Suicides 2(Date:9/4/2008)...TaqMan(R) real-time PCR testing for the diagnostic..., Calif., Sept. 4 /- The U.S. Food & ...OBAS(R) TaqMan(R) HBV Test,the first assay for qu....S.,The test uses Roche,s real-time PCR technology...n a patient,s blood. Doctors may use viral load,te...
(Date:9/4/2008)...Enroll 750 Women at More Than 100 Sites in the U.S...Rx Pharmaceuticals, a,privately-held biopharmaceut...ization of compounds to treat endocrine, metabolic...t it has initiated a second,Phase 3 clinical trial...,estrogen-free oral therapy in development for the...
(Date:9/4/2008)...atient Identification for Targeted Therapies ...ment HUNTINGTON BEACH, Calif., and AMSTERDAM, N...ld leader in molecular cancer diagnostics,today a...ostic test that,allows physicians to quantitativel...ogen receptor (ER), progesterone receptor (PR) and...
(Date:9/3/2008).... 3 /- Simcere,Pharmaceutic... supplier of,branded generic pharmaceuticals and m...oduct Endu (also known as Endostar) in China,anno...l study., At the request of the SFDA, Simcere ini...te the safety and therapeutic efficacy of Endu, a ...
Breaking Medicine Technology:FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Agendia Launches TargetPrint(R) for Breast Cancer Patients 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3China Clean Energy Updates Business Outlook 6279 1China Clean Energy Updates Business Outlook 6279 2China Clean Energy Updates Business Outlook 6279 3New York Resident Elected President of Lions Clubs International 22871 1New York Resident Elected President of Lions Clubs International 22871 2Medical Machines Online Announces the Overstock and Release of a New ECG Machine 22868 1Medical Machines Online Announces the Overstock and Release of a New ECG Machine 22868 2Urgent Care Provider NextCare Introduces CareForToday Medical Insurance Plan 22865 1Urgent Care Provider NextCare Introduces CareForToday Medical Insurance Plan 22865 2...June 1, 2007-Cytos Biotechnology AG is delighted t...ations of its novel,immunotherapeutic CYT003-QbG10...inical results for CYT003-QbG10 were obtained,and ...I Congress of,the European Academy of Allergology ... June 9-13, 2007 in Göteborg,Sweden. The EAA...
... Final Analysis of the Results, ISTA Plans to Init...E, Calif., May 31, 2007 /PRNewswire-FirstCall/ -- ...ive results from the,preliminary analysis of the C..., which is being developed as a treatment for dry ...achieved a strong,trend in the objective sign of b...
Other Medicine Technology:CYT003-QbG10 to treat allergy to be presented at the Congress of,the European Academy of Allergology and Clinical Immunology,(EAACI), June 9-13, 2007 2ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 2ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 3ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 4ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 57 mm blade, angled right. Flat handle.
1 mm diameter. Angled 33 degrees. Round handle.
3.5 mm blade. Round handle. Designated most popular model or size.
7 mm curved blade. Round handle.
Medicine Products: